Literature DB >> 1977580

Guanethidine-mediated destruction of ovarian sympathetic nerves disrupts ovarian development and function in rats.

H E Lara1, J K McDonald, C E Ahmed, S R Ojeda.   

Abstract

Immunosympathectomy produced by treatment of newborn rats with antibodies to nerve growth factor (NGF) delays ovarian development and disrupts estrous cyclicity. While these alterations have been ascribed to loss of sympathetic neurons innervating the ovary, the treatment also causes partial loss of ovarian sensory innervation. The present experiments were undertaken to determine if selective interference with ovarian noradrenergic/sympathetic action would result in alterations of ovarian development similar to those caused by NGF antibodies (NGF Ab). We have used two approaches to disrupt catecholamine action on ovarian cells: 1) inhibition of beta-adrenoreceptors by local delivery of receptor blockers to the ovaries of juvenile rats; and 2) elimination of the sympathetic innervation by long term postnatal treatment with guanethidine (GD), an adrenergic neuron blocking agent. When GD is administered chronically it produces an autoimmune-mediated destruction of peripheral sympathetic nerves, without affecting cholinergic or sensory neurons. Of the receptor blockers tested, FM-24, a nonreversible antagonist, resulted in a sustained 70% decrease in available receptors throughout the 10-day period studied. In spite of this, the timing of puberty, assessed by the age at vaginal opening and first ovulation, was not delayed, suggesting that activation of the remaining receptors by an intact innervation suffices to maintain a normal noradrenergic influence. GD treatment initiated at the end of the first week of postnatal life and maintained for three weeks slowed the juvenile-peripubertal rate of body growth, delayed the time of vaginal opening and first ovulation, and disrupted subsequent estrous cyclicity, but did not affect the animals' fertility. The ovaries of GD-treated rats exhibited a striking loss of sympathetic (norepinephrine and neuropeptide Y) nerves but a normal sensory innervation (represented by fibers containing calcitonin gene-related peptide). The concentration of beta-adrenoreceptors in granulosa cells was reduced, suggesting follicular immaturity. Direct assessment of this inference by morphometric analysis of the ovaries revealed that follicular development was retarded. The progesterone and estrogen response of juvenile ovaries to gonadotropins in vitro were also reduced. At this time, circulating LH levels were slightly decreased, but neither LHRH content in the median eminence nor the LHRH response to prostaglandin E2 in vitro were affected.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1977580     DOI: 10.1210/endo-127-5-2199

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  18 in total

Review 1.  Role of stress and sympathetic innervation in the development of polycystic ovary syndrome.

Authors:  Monika Greiner; Alfonso Paredes; Verónica Araya; Hernán E Lara
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.633

Review 2.  Functional significance of the innervation of the gonads.

Authors:  Ida Gerendai; Péter Banczerowski; Béla Halász
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.633

3.  Functional development of the ovarian noradrenergic innervation.

Authors:  Manuel Ricu; Alfonso Paredes; Monika Greiner; Sergio R Ojeda; Hernan E Lara
Journal:  Endocrinology       Date:  2007-10-18       Impact factor: 4.736

4.  Effects of capsaicin treatment on the regulation of ovarian compensatory hypertrophy and compensatory ovulation.

Authors:  Angélica Trujillo; Leticia Morales; Xiomara Vargas; Leticia Alba; Roberto Domínguez
Journal:  Endocrine       Date:  2004-11       Impact factor: 3.633

5.  Effects of adrenalectomy on the stress-induced changes in ovarian sympathetic tone in the rat.

Authors:  A Gálvez; A Paredes; J L Fiedler; M Venegas; H E Lara
Journal:  Endocrine       Date:  1999-04       Impact factor: 3.633

6.  Ovarian effects of prenatal exposure to benzo[a]pyrene: Roles of embryonic and maternal glutathione status.

Authors:  Ulrike Luderer; Meagan B Myers; Malathi Banda; Karen L McKim; Laura Ortiz; Barbara L Parsons
Journal:  Reprod Toxicol       Date:  2017-03-06       Impact factor: 3.143

Review 7.  Hormonal programming across the lifespan.

Authors:  B M Nugent; S A Tobet; H E Lara; A B Lucion; M E Wilson; S E Recabarren; A H Paredes
Journal:  Horm Metab Res       Date:  2012-06-14       Impact factor: 2.936

8.  Vasoactive intestinal peptide (VIP)-mediated expression and function of steroidogenic acute regulatory protein (StAR) in granulosa cells.

Authors:  Mariusz P Kowalewski; Matthew T Dyson; Alois Boos; Douglas M Stocco
Journal:  Mol Cell Endocrinol       Date:  2010-07-23       Impact factor: 4.102

Review 9.  Convergence of multiple mechanisms of steroid hormone action.

Authors:  S K Mani; P G Mermelstein; M J Tetel; G Anesetti
Journal:  Horm Metab Res       Date:  2012-03-27       Impact factor: 2.936

10.  Increases in norepinephrine release and ovarian cyst formation during ageing in the rat.

Authors:  Eric Acuña; Romina Fornes; Daniela Fernandois; Maritza P Garrido; Monika Greiner; Hernan E Lara; Alfonso H Paredes
Journal:  Reprod Biol Endocrinol       Date:  2009-06-16       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.